Introduction {#Sec1}
============

Microarrays are invaluable tools for measuring transcriptional responses of cells and tissues. The most common and perhaps the most fundamental question that is asked is whether observed differences in gene expression are statistically significant. Traditionally, a fold-change cutoff has been used as an indicator of significance. Although fold-change can be a consistent measure at high signal intensities, it is not very reliable when the signals are low. Low intensities are therefore filtered out prior to applying a fold change threshold, leaving these genes poorly interpreted. More rigorous statistical techniques are therefore desired to overcome these limitations.

The variance structure of microarray data has been widely known and modeled by a number of groups (Ideker et al. [@CR5]; Li and Wong [@CR7]; Rocke and Durbin [@CR9]). It is believed that this variance structure can be decomposed into an expression-dependent and an expression-independent component. The approaches generally taken however, have been to "normalize" the microarray data to remove this undesired behavior, and process the resultant data with existing statistical tests (Sasik et al. [@CR11]; Durbin and Rocke [@CR3]; Irizarry et al. [@CR6]). We have taken a fundamentally different approach to this problem. Recognizing that the sample variance is itself a poor estimator of noise at low replicate numbers (*n* = 2--3), we hypothesized that the variance structure itself could be used as a more precise estimator of variance (Hsiao et al. [@CR4]). We subsequently devised a modeling procedure to identify the maximum likelihood estimates of expression-dependent and expression-independent variance. This model was then incorporated directly into a Bayesian statistical test.

In addition to normalization strategies, several statistical methods have been described to interpret gene expression data. Non-parametric methods such as Significance Analysis of Microarrays (SAM) (Tusher et al. [@CR13]) are widely applicable because they do not rely on explicit assumptions about the error structure. These non-parametric methods, however, lack sensitivity in the absence of high levels of replication. On the other hand, parametric methods such as the *t*-test and Bayesian variants like Cyber-T (Baldi and Long [@CR1]) can be powerful because of their ability to extrapolate the behavior of variability based on prior assumptions about the error structure. By parameterization, these methods reduce the minimum number of array replicates needed to identify significant changes in gene expression. Despite these advances however, existing methods still require many replicates to achieve sufficient sensitivity for biological interpretation.

We present a novel statistical approach for the interpretation of microarray functional genomics data that can be performed on as few as one measurement per experimental condition. Our method, the BMA (Bivariate Microarray Analysis) is based on the Bayesian framework developed in Hsiao et al*.* ([@CR4]) for the interpretation of one-channel array data. In addition to modeling the relationship between signal intensity and variance, BMA also models the covariation between the two color channels. We demonstrate in simulated data the dramatically increased sensitivity of BMA over other standard approaches, particularly at low replicate numbers (*n* = 2). This remains true independent of whether we choose an array-wide false-positive rate (*α*~Bonf~) or a false discovery rate (FDR) as a significance threshold. Lastly, we show that when BMA is applied to a time course study of lipopolysaccharide (LPS)-treated macrophages, the differential gene expression pattern found with a single dye-swapped pair is very similar to that detected with three dye-swap pairs.

Statistics and modeling {#Sec2}
=======================

Bayesian framework {#Sec3}
------------------

The mean of intensity measurements is typically used as a point estimate for gene expression and the variance from that mean is used as an indicator of variability. Our method relies on the notion that a model that fits the error structure of microarray data will be a better estimator of variability. By integrating this variance model into a Bayesian framework, which is discussed more thoroughly in Supporting Information Sect. I, we transform the mean intensity into a probability density for gene expression. The resulting probability density describes the likely values for "true expression level" (*μ*). We can then apply statistical tests on this density to determine which genes are differentially-expressed between two experimental conditions. The foundation of our approach, then, lies at accurately modeling the amount of noise in microarray data.

The error structure of microarray data {#Sec4}
--------------------------------------

Microarray gene expression data displays greater fractional error at low signal intensities than at high intensities. When the same RNA samples are analyzed on multiple arrays, this relationship is still present, indicating that much of this variation comes from the microarray platform itself. We believe that platform-specific factors, such as the resolution of the microscope and dye system, fundamentally limit the reliability of low-intensity measurements. We refer to this type of noise as expression-independent variance (*B*). At greater signal intensities, this physical limit becomes less and less important. Here, expression-dependent variance (*A*) begins to dominate, but both kinds of error are small compared to the signal. By itself, this simple model can explain much of the variance behavior in a single channel.

In a two-channel microarray, measurements are obtained from two RNA samples labeled with different dyes. These samples are subsequently hybridized with the microarray probes (Brown and Botstein [@CR2]). Since these probes are spotted, rather than synthesized directly on the array surface, there can be considerable variability between the amounts of probe spotted between arrays. This variation in "probe intensity" alters the intensity measurements for both color channels, and leads to covariation of the paired signals. We therefore chose to model this covariation by introducing correlation coefficients for expression-dependent and expression-independent variance. The final variance model contains a total of six parameters. These parameters are related to the treatment variances (*σ*~1~, *σ*~2~) and correlation (*ρ*) through:$$\documentclass[12pt]{minimal}
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Parameter estimation {#Sec5}
--------------------

Parameters for the variance model can be computed by Markov Chain Monte Carlo (MCMC) simulation of the bivariate normal density. This simulation computes the maximum likelihood estimates for each of the six variance parameters. Since the "true" gene expression is not known prior to observing array measurements, the observed sample mean is used as a surrogate. This choice, although necessary, can be problematic at low intensities. With the sample mean as a surrogate for true expression, poor signal-to-noise ratios can cause underestimation of true variability. Therefore, we have devised an estimation technique that identifies parameters which are stable against an expression-level cutoff.

Model parameters should be the same regardless of how much data is used to estimate them. Thus, we may progressively discard increasing numbers of low-intensity features to avoid the downward bias caused by low signal-to-noise. In Fig. [1](#Fig1){ref-type="fig"}, we demonstrate the effect of these cutoffs on estimates of expression-independent error. This parameter has two regions that are relatively stable against successive quantile cutoffs. When smaller cutoffs are used, expression-independent error tends to be underestimated. When larger cutoffs are used, the parameters become unstable. The details of the modeling procedure are discussed in Supporting Information Sect. II. It is also important to note that the expression-level cutoff defined here is only used to improve the quality of parameter estimates. The resulting variance model is applied across the entire array. By combining this model with the Bayesian framework described earlier, we can then use a statistical test to determine the significance of observed differences in gene expression.Fig. 1Estimation of expression-independent error in a sample data set. The estimation procedure computes parameters for a series of expression-level quantile cutoffs. Array features with average measurements below the cutoffs are discarded, and the most likely parameters for the remaining data are computed. In this figure, each point on the colored surface describes the estimated value of expression-independent error ($\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ \sqrt {\hat{B}_{2} } $$\end{document}$) for a given pair of cutoffs. There are two rectangular regions where expression-independent error appears to be stable. These regions are identified by arrows

Statistical test {#Sec6}
----------------

In order to make BMA compatible with conventional concepts widely understood by the biological research community, we devised a statistical test that computes a *P*-value. This *P*-value may be used to control type I error, which is the rate at which the null hypothesis is incorrectly rejected. In BMA, we define the null hypothesis (*H*~0~) to be that the "true" gene expression does not change across two experimental conditions. The alternative hypothesis (*H*~1~) is accepted when the null hypothesis is rejected. In other words, we test$$\documentclass[12pt]{minimal}
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The *P*-value of BMA is defined in a way similar to that of a *t*-test. In a *t*-test, the *P*-value is defined as an integral of a *t*-distribution. When the "tail area" of the *t*-distribution is sufficiently small, we consider experimental results to be statistically significant. In BMA, we define the *P*-value as a two-dimensional integral of a bivariate normal density. In other words, we determine whether the "tail volume" of this distribution is sufficiently small. If so, we consider the gene to be differentially-expressed. A depiction of the bivariate integral is shown in Fig. [2](#Fig2){ref-type="fig"}. Explicitly,$$\documentclass[12pt]{minimal}
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\begin{document}$$ p_{i} = \left\{ {\begin{array}{*{20}c} {\int_{ - \infty }^{\infty } {\int_{ - \infty }^{{\mu_{2} }} {\pi_{i} \left( {\mu_{1} ,\mu_{2} } \right)d\mu_{1} } \cdot d\mu_{2} ,} } & {E\left[ {\mu_{1} } \right] > E\left[ {\mu_{2} } \right]} \\ {\int_{ - \infty }^{\infty } {\int_{{\mu_{2} }}^{\infty } {\pi_{i} \left( {\mu_{1} ,\mu_{2} } \right)d\mu_{1} } \cdot d\mu_{2} } ,} & {E\left[ {\mu_{2} } \right] > E\left[ {\mu_{1} } \right]} \\ \end{array} } \right. $$\end{document}$$where *π*~*i*~ is the joint posterior density for the "true" expression levels of the *i*th feature.Fig. 2Depiction of the significance integral. The statistical test performed by BMA involves integration of a bivariate normal density. The peak of the density appears on one side of the diagonal line. The *P*-value is defined as the "tail volume" on the side opposite of the peak. Statistical significance is achieved when the *P*-value is smaller than a specified threshold. The bivariate normal density depicted in (**a**) was sufficiently distant from the diagonal, and was considered a "significant" change (*α*~Bonf~ = 0.05). The density depicted in (**b**) was too close to the diagonal, and therefore does not represent a significant difference in gene expression

A solution to the integration of the bivariate normal is given in Supporting Information Sect. III. When the *P*-value is less than the significance threshold, we reject the null hypothesis that *μ*~1~ = *μ*~2~, and consider the difference in gene expression to be statistically significant. The results of this test, when applied to a LPS-treated macrophage data set, are shown in Fig. [3](#Fig3){ref-type="fig"}.Fig. 3A scatter plot demonstrating the results of BMA on macrophages treated with LPS for 1 h (*α*~Bonf~ = 0.05). Each point represents the average signal measured from an array feature (*n* *=* 2). Highlighted dots appear farthest from the diagonal, indicating statistical significance

Specifying a significance threshold {#Sec7}
-----------------------------------

There are two commonly used methods for determining a useful significance threshold (*α*) when analyzing microarray data. If we are interested in maintaining an array-wide false positive rate, we may set a Bonferroni-corrected threshold (*α*~Bonf~). This is equivalent to the number of features we expect to appear as significant by random chance alone. If we set *α*~Bonf~ = 0.05, then we expect only one feature to be significant when analyzing 20 batches of microarray experiments. Needless to say, this is a tremendously strict significance threshold. When the number of features is large, the *P*-value threshold for a two-sided test is$$\documentclass[12pt]{minimal}
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In some cases, the false discovery rate (*FDR*) may be preferred. It is typically less stringent, but can still provide meaningful results. Assuming that the *P*-value defined here gives a reasonable estimate for the type I error, the false discovery rate is related to the array-wide false positive rate by$$\documentclass[12pt]{minimal}
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Results {#Sec8}
=======

Simulated data {#Sec9}
--------------

We tested the accuracy of several statistical methods on simulated data sets derived from the estimated variance structure of a two-color data set recently published by Rome et al*.* ([@CR10]). The authors analyzed the RNA content of human skeletal muscle biopsies collected before and after application of a hyperinsulinemic euglycemic clamp. Sample measurements for our simulated set were obtained from lognormal distributions centered on the pre-clamp mean intensities. The second treatment condition was obtained by "spiking" 10% of the features. The sample means of these randomly selected features were multiplied or divided by a random number between 1 and 20. Since the signal-to-noise ratio (SNR) is much greater at higher signal intensities, it is likely that subtle changes are more readily picked up at high levels of gene expression. This model problem therefore contains both subtle and dramatic gene expression changes at a variety of intensity levels.

Prior to identifying the "spiked" features, we tested the accuracy of two different modeling procedures. An equivalent model for the variance structure of two-color microarray data was previously proposed by Ideker et al*.* ([@CR5]). We applied their modeling approach, VERA (Variability and Error Assessment) along with our own, to compare parameter accuracy (Fig. [4](#Fig4){ref-type="fig"}). Even with two replicates, BMA showed striking accuracy in its estimate of expression-independent variance. VERA underestimated this parameter even with large replicate numbers (*n* = 16). We attribute the accuracy of BMA to the cutoff procedure, which reduces the effect of poor-quality measurements at low intensities. Since expression-independent variance dominates at low intensities, this precision is essential for interpreting faintly-expressed genes. In addition, both approaches had a tendency to underestimate expression-dependent variance when only two replicates were used, but improved with more replicates.Fig. 4The variance structure estimated by BMA tightly fits the RMSD (root mean square deviation) as well as the underlying variance model. The simulated data set shown here was obtained by sampling from a 'true' model derived from the Rome et al*.* ([@CR10]) two-color data set. The quality of fit to RMSD is shown for **a***n* = 2 and **b***n* = 16 in non-transformed coordinates. The vertical dashed line indicates the location of the quantile cutoff used to estimate the variance parameters. The diagonal line labeled "Max RMSD" shows the maximum possible value for RMSD at each expression level. The variance model estimated by BMA tightly matches the 'true' model, particularly at low intensities. This accuracy was not matched by VERA and SAM, even when large numbers of replicates were used

With these variance parameters, we then compared the accuracy of four different methods in identifying "differentially-expressed" genes. This comparison was performed using three different thresholds of statistical significance. The quality of the predictions is displayed in Table [1](#Tab1){ref-type="table"}. Each of the statistical tests demonstrates improved sensitivity as significance thresholds were loosened and as larger numbers of experimental replicates were used. As we would expect, the FDR significance threshold was often predictive of the true false-positive rate. There is only one clear case where the false-positive rate substantially exceeded the desired FDR. At *n* = 2 and FDR = 0.05, BMA shows a loss in specificity. This results because expression-dependent variance was underestimated at *n* = 2. When the variance model derived from *n* = 6 data was used, the loss of specificity was reversed. In all other cases, our method appears to be much more sensitive than existing methods without sacrificing specificity.Table 1Simulated data sets of 20,000 features, 2,000 spiked genes were analyzed with four different methods to determine the accuracy of predictions of differential-expressionThresholdMethodTPFPFPRFNRSensitivitySpecificity*n* *=* *2α*~Bonf~ = 0.05BMA40400.0000.0810.2021.000Cyber-T paired7800.0000.0960.0391.000*λ*~*c*~ = 23.8VERA and SAM27490.0320.0880.1371.000FDR = 0.001BMA657140.0210.0690.3290.999Cyber-T paired13900.0000.0940.0701.000SAM paired00N/A0.1000.0001.000FDR = 0.05BMA1,1714420.2740.0450.5860.975BMA (*n* *=* 6 model)47250.0100.0780.2361.000Cyber-T paired54230.0060.0750.2711.000SAM paired13010.0080.0940.0651.000*n* *=* *6α*~Bonf~ = 0.05BMA93700.0000.0560.4691.000Cyber-T paired26900.0000.0880.1351.000*λ*~*c*~ = 23.8VERA and SAM1,15540.0030.0450.5781.000FDR = 0.001BMA1,21130.0020.0420.6061.000Cyber-T paired38700.0000.0820.1941.000SAM paired00N/A0.1000.0001.000FDR = 0.05BMA1,5141380.0840.0260.7570.992Cyber-T paired92520.0020.0560.4631.000SAM paired26680.0290.0880.1331.000*n* *=* *16α*~Bonf~ = 0.05BMA1,47930.0020.0280.7401.000Cyber-T paired82900.0000.0610.4151.000*λ*~*c*~ = 23.8VERA and SAM1,554340.0210.0240.7770.998FDR = 0.001BMA1,589160.0100.0220.7950.999Cyber-T paired1,09600.0000.0480.5481.000SAM paired93000.0000.0560.4651.000FDR = 0.05BMA1,7181600.0850.0160.8590.991Cyber-T paired1,44160.0040.0300.7211.000SAM paired1,601610.0370.0220.8010.997The number of true-positives (*TP*), number of false-positives (*FP*), false-positive rate (*FPR*), false-negative rate (*FNR*), sensitivity, and specificity are reported for each method when either the Bonferroni-corrected threshold (*α*~Bonf~) or false discovery rate (*FDR*) are controlled. BMA demonstrates substantial improvements in sensitivity across all significance thresholds investigated. A considerable loss of specificity was only observed at low replicate numbers (*n* = 2) when the significance threshold is loose (FDR = 0.05)

These results show that BMA can accurately predict genes that are differentially-expressed. The variance-modeled approach is particularly beneficial at low replicate numbers where other statistical methods fail. In these conditions, the variance model estimates variability more accurately than traditional statistics. Applying this model in a Bayesian framework translates into improved sensitivity for subtle changes in gene expression.

Time-course study of LPS-treated macrophages {#Sec10}
--------------------------------------------

We also examined the effectiveness of our method along with several others on two-channel microarray data available from the Alliance for Cellular Signaling (AfCS). \[Reference: <http://www.signaling-gateway.org>\]. In this data set, three pairs of dye-swapped measurements were obtained for each of six time points during lipopolysaccharide (LPS) treatment of RAW 264.7 macrophages, for a total of 36 arrays. Data sets such as this are valuable for understanding the dynamics of gene expression in response to ligand. In addition, much is already known about the behavior of macrophages in the presence of LPS. This is an ideal system then, to determine whether it is possible to interpret gene expression responses while using fewer microarray replicates.

When all three dye-swap replicates are available, similar sets of differentially-expressed genes can be obtained by any of the previously described methods. At the 8 h time point, for example, 1,492 genes were detected as differentially-expressed by BMA, SAM, and Cyber-T (FDR = 0.001). In contrast, only 300 were detected solely by BMA, 279 solely by SAM, and 105 solely by Cyber-T. The methods differ tremendously with fewer array replicates, however. When SAM is given fewer than three dye-swap pairs, no significance threshold can be found that satisfies the desired false-discovery rate. With Cyber-T, similar to what is observed in simulated data, far fewer numbers of significant gene expression changes are detected when either two dye-swap pairs (*n* = 4) a single dye-swap pair (*n* = 2) are used (Fig. [5](#Fig5){ref-type="fig"}). In contrast, our method detects similar numbers of gene changes regardless of how many replicates are used in analysis. This is further confirmed by comparing the sets of differentially expressed features (Figs. [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}). Despite using only the information contained in a single dye-swap pair, BMA identifies equivalent sets of significant changes. Furthermore, we found that similar Gene Ontology (GO) terms were statistically enriched whether we used a single dye pair or all of the available data (Table [2](#Tab2){ref-type="table"}). In particular, genes involved in cell death and proliferation were strongly regulated by LPS. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were also similarly enriched (Supporting Information). Therefore, although increased sensitivity can be gained by increasing replicate number, BMA allows us to make meaningful biological interpretations of two-channel functional genomics data with only a single dye-swap pair.Fig. 5BMA can use as little as a single pair of dye-swapped measurements to identify an equivalent number of statistically significant gene expression changes in the LPS-treated RAW 264.7 data set at all six time points. The quantity of significant gene changes (α~Bonf~ = 0.05) stays relatively constant whether or not more replicates are used. Cyber-T's results approach BMAs as the number of replicates increaseFig. 6The identity of genes identified by BMA and Cyber-T are very similar at the 8 h when all replicate data is used (*n* = 6). BMA also obtains similar results when fewer replicates are used (*n* = 2). A significance threshold of α~Bonf~ = 0.05 was used for all methodsFig. 7The identity of genes identified by BMA, Cyber-T, and SAM are similar at 8 h when all replicate data is used (*n* = 6). A significance threshold of FDR = 0.001 was used for all methodsTable 2Statistically enriched GO terms among differentially-expressed features after 1 h of LPS treatment (BMA, *α*~Bonf~ = 0.05)GO IDGO term nameCount*P*-value*n* *=* *2*GO:0006952Defense response460.0000000000GO:0006954Inflammatory response200.0000000000GO:0006955Immune response410.0000000000GO:0009607Response to biotic stimulus480.0000000000GO:0045087Innate immune response200.0000000000GO:0009605Response to external stimulus510.0000000001GO:0009611Response to wounding220.0000000001GO:0009613Response to pest/pathogen/parasite240.0000000041GO:0050896Response to stimulus530.0000000047GO:0005125Cytokine activity220.0000000060*n* *=* *6*GO:0006952Defense response480.0000000000GO:0006955Immune response440.0000000000GO:0009607Response to biotic stimulus510.0000000000GO:0009611Response to wounding250.0000000000GO:0006954Inflammatory response210.0000000001GO:0045087Innate immune response210.0000000001GO:0006915Apoptosis300.0000000007GO:0012501Programmed cell death300.0000000010GO:0009613Response to pest/pathogen/parasite270.0000000021GO:0009605Response to external stimulus540.0000000060The number of features annotated with the GO term and the *P*-value are also displayed. Only the 10 GO terms with the lowest *P*-values are shown. All displayed GO terms are significantly enriched (*α*~Bonf~ = 0.05). The complete lists are provided in the Supporting Information

We further examined the 985 features that were uniquely found by BMA with only two replicates at the 8 h time point. Among these were 17 features associated with components of the toll-like receptor signaling pathway as defined by KEGG. This list includes prominent figures such as toll-like receptor 2 (Tlr2) and toll-like receptor 4 (Tlr4). Tlr4 is believed to be required for LPS-induced signaling (Ulevitch and Tobias [@CR14]), while expression of Tlr2 and Tlr4 have previously been confirmed to be induced in murine alveolar macrophages by LPS (Oshikawa and Sugiyama [@CR8]). Furthermore, it has long been known that LPS stimulation induces macrophage expansion in vivo (Yokochi et al. [@CR15]). This effect on gene expression is striking at the 8 h time point, as BMA found 115 additional features involved in cell proliferation. As macrophages play a major role in antigen presentation of exogenous peptides, it is also interesting to note that seven additional features involved in MHC class I and one additional feature involved in MHC class II antigen presentation were also upregulated. This included several HLA loci and β~2~-microglobulin. Class II MHCs are commonly thought to present exogenous antigens, but recent evidence has shown that immunity against *Mycobacterium tuberculosis* requires presentation on class I MHCs in a 'detour' pathway (Schaible et al. [@CR12]). The consistency of these results with known macrophage physiology is strongly suggestive of the quality of genes detected by BMA. Furthermore, these 985 features would have been entirely missed by other methods if only two replicates were used.

Discussion {#Sec11}
==========

In our analysis of the performance of BMA against present statistical methods, BMA provides improved sensitivity at all significance thresholds and replicate numbers tested. A loss of specificity was only observed in a simulated data set when both (a) the variance model was not sufficiently accurate and (b) a loose false discovery rate was desired. In the LPS-treated macrophage data set, the significant features detected with three dye-swap replicates were not substantially different from the features detected with a single dye-swap replicate. Thus, a loss of specificity does not appear be an issue when a stringent significance threshold is applied. In addition, since no additional experiments need to be performed to compute this threshold, our method is immediately applicable to existing data sets.

The scope of microarray expression profile studies has been limited by the costs of producing sufficient numbers of arrays to accommodate present statistical methods. BMA approaches this fundamental limitation by modeling the relationships between variability and gene expression, and applying this array-wide model as a more accurate indicator of error. Although some previous attempts at modeling the sources of noise have been described (Ideker et al. [@CR5]; Li and Wong [@CR7]; Rocke and Durbin [@CR9]), much of the literature is devoted to "normalizing" array data to reduce variability. While these forms of normalization are not necessarily incompatible with BMA, we believe they may actually introduce additional artifacts, particularly when their assumptions are too strong. For example, quantile and lowess normalization fail to account for the poor signal-to-noise ratios at low intensities. When we modeled variance parameters for unnormalized data, we found a dramatic decrease in expression-independent variance (Supporting Information Sect. II). Expression-dependent variance was slightly increased. More importantly though, we found that the expression-independent correlation coefficient (*ρ*~B~) converged on a more realistic value, and was vastly more stable against quantile cutoffs. This suggests to us that the underlying variance structure at low intensities is clouded by these forms of normalization, and that caution should be exercised in using these procedures. With BMA, meaningful results can be obtained from raw data with minimal manipulation.

Furthermore, we believe that the current approaches for normalizing variability may ultimately be limited by the use of conventional statistical tests, which rely on large levels of replication to demonstrate significance. The levels of replication demanded by these methods do not frequently exist because of financial and labor constraints. They are even less likely to exist in multiple-ligand and time-course studies. BMA takes advantage of the parallel nature of microarrays to reduce replicate number. Two channel arrays have tremendous untapped potential for large-scale studies of functional genomics. We anticipate that because of BMAs improved sensitivity at low replicate numbers, it will provide (1) more consistent interpretations of array data and (2) an avenue for implementing more sophisticated experimental designs.

Conclusions {#Sec12}
===========

We have demonstrated here the effectiveness of our variance-modeled Bayesian approach on paired microarray data. BMA provides improved sensitivity at all significance thresholds and replicate numbers tested. The present method provides a reliable approach to identifying a set of differentially-expressed features with an a priori-specified significance threshold. Since existing statistical tests are unable to produce comparable results at low replicate numbers, this represents a substantial advance in microarray statistics.

Methods {#Sec13}
=======

In order to assess the effectiveness of several current statistical approaches, we created a simulated data set based on the error structure of the previously published data set of Rome et al*.* ([@CR10]). We computed variance parameters from this data set and used this model to generate random paired-samplings from a lognormal density centered on the sample means. The simulated data set contains 20,000 features. 10% of these features were randomly chosen to be spiked by multiplying the sample mean by e^*s*^, where *s* is a sampling from a uniform random variate with support on \[−log~e~(20), log~e~(20)\].

In our analysis with VERA and SAM (Ideker et al. [@CR5]), we used a likelihood ratio cutoff of λ~c~ = 23.8 for statistical significance. For Cyber-T, we performed paired analysis with *ν* = 10, and detected significance in two ways: using *α*~Bonf~ = 0.05 and manually adjusting *α*~Bonf~ to achieve the desired false-discovery rates of 0.001 and 0.05. False-discovery rates in SAM were adjusted by adjusting Δ until the desired FDR were achieved. For both versions of BMA, we implemented an automated procedure that identifies the appropriate *α*~Bonf~ for the desired FDR, based on golden section root finding. A lower bound for *α*~Bonf~ was set at the minimum achievable FDR. The range of *α*~Bonf~ was subsequently adjusted using Eq. [7](#Equ7){ref-type=""} until *α*~Bonf~ could be narrowed to within 10^−5^. To determine the minimum achievable FDR, we similarly used a golden section minimization strategy.

To demonstrate the effectiveness of each method on real data, the AfCS LPS-treated RAW 264.7 Agilent inkjet-deposited oligo data set was obtained from the AfCS web site at <http://www.signaling-gateway.org/>. The processed signal intensities were normalized with intensity-dependent lowess normalization to standardize signals between arrays, although similar results were obtained by BMA without normalization. In order to identify a stable set of variance parameters, a single variance model was obtained from a pooled data set containing all six time points. This model was then applied to all six time points to determine differential expression.

Statistical enrichment of Gene Ontology terms and KEGG pathways was computed by comparing the number of "significant" features annotated with a particular GO term to the background. For the background, we used all of the features on the Agilent array. Exact likelihoods (*P*-values and *q*-values) were computed directly from the hypergeometric distribution.

The modeling procedure and the bivariate microarray analysis were implemented in a set of command-line JAVA tools. These tools have been added to the VAMPIRE ([Va]{.ul}riance-[M]{.ul}odeled [P]{.ul}osterior [I]{.ul}nference with [R]{.ul}egional [E]{.ul}xponentials) statistical package, and are available from our website at <http://genome.ucsd.edu/microarray>. The MCMC framework used in VAMPIRE and BMA is a freely available JAVA package known as Hydra. The CustomMetropolisHastingsSampler is used to carry out the simulation, with a NormalMetropolisComponentProposal generating potential states. In addition, we used the open source library COLT for random number generation.
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BMA

:   Bivariate microarray analysis

VAMPIRE

:   Variance-modeled posterior inference with regional exponentials

FDR

:   False discovery rate

RMSD

:   Root mean square deviation

AfCS

:   Alliance for cellular signaling

GO

:   Gene ontology

KEGG

:   Kyoto encyclopedia of genes and genomes

MHC

:   Major histocompatibility complex

LPS

:   Lipopolysaccharide
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Availability: The statistical approach presented here is implemented as a set of Java-based tools, accessible at our website, <http://genome.ucsd.edu/microarray>.
